Biogen shares slide as Medicare proposal restricts coverage of Alzheimer's treatments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall St slides after strong jobs report bolsters hawkish Fed bets
- US nonfarm payrolls surge in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil slides on Friday, heads for weekly gain on US-Iran fight
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
BMO Capital Sees Upside for Biogen (BIIB) if We Get 'Serious Strategic Pivot'
January 13, 2022 1:26 PM ESTBMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $290.00 price target on Biogen (NASDAQ: BIIB) following today's Q&A analyst call. The analyst sees upside potential for the stock if/when a serious strategic pivot is announced.
The analyst commented,... More
